Most in vitro and ex-vivo studies indicate a profound suppression of NK cell cytotoxicity (NKCC) by glucocorticoids; while catecholamines and prostaglandins were reported both to suppress and to enhance NKCC. However, methodological considerations hinder our ability to deduce from these findings to the impact of endogenous release of these factors on in vivo levels of NKCC and their implications to NKdependent resistance to pathologies in living humans or animals. Here we used an in vivo approach that sensitively and specifically reflects NKCC in living F344 rats, based on lung clearance of NK-sensitive tumor cells (MADB106), and based on comparing effects between NK-intact and NK-depleted rats. To study the role of corticosterone, epinephrine, and prostaglandins, we administered these factors to rats, or antagonized their endogenous release following different stress paradigms or surgery. The results indicated that endogenous or exogenous elevated corticosterone levels can suppress in vivo NKCC levels, but only under some conditions, and mostly secondarily to the NK-suppressing impact of epinephrine. Specifically, corticosterone-induced NKCC suppression occurred (i) only under prolonged, but not short exposure to stress, and mainly in males; (ii) was smaller than the prominent impact of epinephrine; (iii) was mostly ascribed to corticosterone-induced potentiation of the effects of epinephrine or/and prostaglandins; and (iv) was completely abolished through antagonizing epinephrine or/and prostaglandins. Overall, these findings markedly limit the significance of stress/surgery-induced corticosterone release in the in vivo suppression of NKCC, and highlight the blockade of epinephrine or/and prostaglandins as effective and clinically feasible approaches to overcome such immuno-suppressive effects.
Introduction
Prominent among stress responses are the systemic release of glucocorticoids and catecholamines, which were repeatedly shown to modulate various aspects of the immune system, including natural killer (NK) cell activity (Neeman et al., 2012; Tarr et al., 2012) , which is an essential aspect of innate immunity, controlling virally infected cells and malignant cells (Reyburn et al., 1997) . Specifically, surgery, swim stress, wet-cage exposure, anxiety, or social confrontation were all shown to suppress NK cytotoxicity (Andersen et al., 1998; Ben-Eliyahu et al., 1999; Levi et al., 2011; Koga et al., 2001) or NK cell capacity to release IFN-gamma (Witek-Janusek et al., 2008; Hiraki et al., 2007) , in humans or in animals. Furthermore, suppression of NKCC by stress or surgery was shown to promote cancer metastasis in animal models (BenEliyahu et al., 1999; Benish et al., 2008; Glasner et al., 2010) , and human studies indicated associations between perioperative suppression of NKCC and increased long-term cancer recurrence rates (Vallejo et al., 2003) .
Glucocorticoids are considered the major mediators of stressinduced suppression of NKCC, as numerous in vitro studies, employing rodent or human leukocytes, reported profound suppression of NKCC by synthetic glucocorticoid analogs or by physiological concentrations (3 Â 10 À6 to 3 Â 10 À7 M) of corticosterone (CORT) or cortisol (for example Cox et al., 1983; Van Ierssel et al., 1997; Shakhar et al., 2007) . Additionally, others (Tseng et al., 2005) and us (Shakhar and Blumenfeld, 2003) observed ex-vivo suppressive effects of exogenous or stress-induced elevated CORT levels on NKCC (measured in vitro). It was therefore concluded that under stressful conditions, endogenously elevated levels of glucocorticoids are the major or the sole mediators of in vivo suppression of NKCC (Shakhar and Blumenfeld, 2003; Pruett 
